Back to search
Infantile Hemangioma (IH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infantile Hemangioma (IH) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Infantile Hemangioma (IH) trials you may qualify forTo assess and compare the efficacy of systemic beta-blocker therapy with the efficacy and safety of fractional carbon dioxide laser-assisted delivery of a topic…
This is a prospective, randomized controlled trial designed to evaluate the efficacy and safety of low-dose oral propranolol (1 mg/kg/day) combined with monthly…
The purpose of this study is to assess the safety and efficacy of Timolol 0.25% and 0.5% doses.
Infantile hemangioma (IH) is the most common vascular tumor of infancy, characterized by its clinical history. Absent at birth or present under the form of a pr…
This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids a…
The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hema…